ThermoGenesis (NASDAQ: THMO) Prepares Launch of ReadyStart cGMP Suites for Cell & Gene Therapy Companies
ThermoGenesis Holdings, Inc. (NASDAQ: THMO) is engaged as an industry leader in automated cell processing tools and services for cell ...
ThermoGenesis Holdings, Inc. (NASDAQ: THMO) is engaged as an industry leader in automated cell processing tools and services for cell ...
Ainos, Inc. (NASDAQ: AIMD) is engaged as a diversified medical technology company, which is focused on developing innovative point-of-care testing ...
Provention Bio, Inc. (NASDAQ: PRVB) is engaged as a commercial-stage biopharmaceutical company, which is focused on the research, development and ...
WW International, Inc. (NASDAQ: WW), or WeightWatchers, describes itself as a human-focused technology company that offers a “proven, science-based, clinically ...
TCR2 Therapeutics, Inc. (NASDAQ: TCRR) operates as a clinical-stage immunotherapy company, which is focused on the research and development of ...
Altamira Therapeutics, Ltd. (NASDAQ: CYTO) is engaged within the research and development of RNA-based therapies for extrahepatic targets and unmet ...
Reata Pharmaceuticals, Inc. (NASDAQ: RETA) is engaged as a biopharmaceutical company, which is focused on the research, development and commercialization ...
Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) is engaged as an artificial intelligence-driven precision cardiovascular medicine company, which is focused on ...
Timber Pharmaceuticals, Inc. (NYSE American: TMBR) is engaged as a clinical-stage biopharmaceutical company, which is focused on the development and ...
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a Rhode Island-based biopharmaceutical company, which is focused on the development and commercialization of ...
Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.
Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.
Subscribe to our weekly newsletter below and never miss the latest small/micro-cap analysis and investment news from Spotlight Growth.